Natural Product: NPC261181
| Natural Product ID | NPC261181 |
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
| Benzoyl Peroxide |
| IUPAC Name | benzoyl benzenecarboperoxoate |
| Synonyms | Acetoxyl 2.5; Acetoxyl 5; Acne-Aid Cream; Acnecide; Acnecide 10; Acnegel; Acnegel Fte; Acnidazil; Benoxyl; Benoxyl 10; Benoxyl 20; Benoxyl 5; Benzac; Benzac W; Benzagel 10; Benzagel 5; Benzamycin; Benzoyl Peroxide; Brevoxyl; Clear By Design; Clearasil Max 10; Dermoxyl; Dry and Clear; Dry Clear; E928; Epi-Clear; Fostex BPO Bar, Gel, and Wash; Gppe Lotio Gel; Loroxide; Mediclear; Mediclear Acne 10; Mediclear Acne 5; Nericur; Oxy-10; Oxy-10 Cover-Up; Oxy-5; PanOxyl; PanOxyl 10; PanOxyl 10 Acnegel; PanOxyl 10 Aquagel; PanOxyl 2.5 Aquagel; PanOxyl 5 Acnegel; PanOxyl 5 Aquagel; PanOxyl Crm 5; PanOxyl Lot 10; PanOxyl Lot 5; Persa-Gel; Quinoderm 5; Quinoped; Theraderm 10; Theraderm 5; Topex; Ultra Clearasil; Valderma; Vanair; Vanoxide |
| Synthetic Gene Cluster |
n.a. |
| ChEMBL Identifier |
CHEMBL1200370 |
| PubChem CID |
7187 |
| Chemical Classification |
-
CHEMONTID:0000000 [Organic compounds]
-
[CHEMONTID:0002448] Benzenoids
-
[CHEMONTID:0002279] Benzene and substituted derivatives
[CHEMONTID:0004112] Benzoyl peroxides
|
The Chemical Classification was calculated by
Classyfire, a software for chemical taxonomy calculation.
Reference:
DOI:10.1186/s13321-016-0174-y.
Chemical Representations
RDKit 3D
28 29 0 0 0 0 0 0 0 0999 V2000
-0.8621 1.0001 1.2757 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.4432 -0.0305 0.8574 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8706 -0.0317 0.7081 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5916 1.1047 1.0272 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.9558 1.1069 0.8856 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.6021 -0.0091 0.4309 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.8731 -1.1314 0.1175 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5078 -1.1762 0.2444 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6839 -1.1578 0.5454 O 0 0 0 0 0 0 0 0 0 0 0 0
0.6632 -1.0781 0.7136 O 0 0 0 0 0 0 0 0 0 0 0 0
1.3854 -0.1773 -0.0509 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7536 0.5308 -0.8721 O 0 0 0 0 0 0 0 0 0 0 0 0
2.8493 -0.0484 0.0897 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5535 -0.8170 0.9845 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9185 -0.6879 1.1067 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6366 0.2080 0.3464 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9214 0.9755 -0.5493 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5510 0.8528 -0.6789 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.0573 1.9900 1.3902 H 0 0 0 0 0 0 0 0 0 0 0 0
-5.4985 2.0063 1.1412 H 0 0 0 0 0 0 0 0 0 0 0 0
-6.6666 -0.0433 0.3080 H 0 0 0 0 0 0 0 0 0 0 0 0
-5.3493 -2.0468 -0.2499 H 0 0 0 0 0 0 0 0 0 0 0 0
-2.9052 -2.0366 0.0086 H 0 0 0 0 0 0 0 0 0 0 0 0
3.0342 -1.5359 1.6050 H 0 0 0 0 0 0 0 0 0 0 0 0
5.4841 -1.2992 1.8194 H 0 0 0 0 0 0 0 0 0 0 0 0
6.7114 0.3330 0.4194 H 0 0 0 0 0 0 0 0 0 0 0 0
5.3997 1.7186 -1.2016 H 0 0 0 0 0 0 0 0 0 0 0 0
3.0055 1.4804 -1.4042 H 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 7 1 0
7 8 2 0
2 9 1 0
9 10 1 0
10 11 1 0
11 12 2 0
11 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
8 3 1 0
18 13 1 0
4 19 1 0
5 20 1 0
6 21 1 0
7 22 1 0
8 23 1 0
14 24 1 0
15 25 1 0
16 26 1 0
17 27 1 0
18 28 1 0
M END
| Standard InCHIKey |
OMPJBNCRMGITSC-UHFFFAOYSA-N |
| Standard InCHI |
InChI=1S/C14H10O4/c15-13(11-7-3-1-4-8-11)17-18-14(16)12-9-5-2-6-10-12/h1-10H |
| SMILES |
O=C(c1ccccc1)OOC(=O)c1ccccc1 |
  Calculated Properties
Physi-Chem Properties
MedChem Properties
ADMET: Absorption
ADMET: Distribution
ADMET: Metabolism
ADMET: Excretion
ADMET: Toxicity
  Species Source
| Organism ID |
Organism Name |
Taxonomy Level |
Family |
SuperKingdom |
Isolation Part |
Collection Location |
Collection Time |
Reference |
| NPO30900 |
Morinda parvifolia |
Species |
Rubiaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
PMID[7097296] |
| NPO30900 |
Morinda parvifolia |
Species |
Rubiaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[COCONUT] |
| NPO11242 |
Gynochthodes parvifolia |
Species |
Rubiaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[COCONUT] |
| NPO30900 |
Morinda parvifolia |
Species |
Rubiaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[HerDing] |
| NPO21641 |
Onychium lucidum |
Species |
Pteridaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[HerDing] |
| NPO11242 |
Gynochthodes parvifolia |
Species |
Rubiaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TCMID] |
| NPO21641 |
Onychium lucidum |
Species |
Pteridaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TCMID] |
| NPO30900 |
Morinda parvifolia |
Species |
Rubiaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TCM_Taiwan] |
| NPO21641 |
Onychium lucidum |
Species |
Pteridaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TCM_Taiwan] |
| NPO11242 |
Gynochthodes parvifolia |
Species |
Rubiaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
| NPO21641 |
Onychium lucidum |
Species |
Pteridaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
☉ UNPD: Universal Natural Products Database [PMID: 23638153].
☉ StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
☉ TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
☉ TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
☉ TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
☉ TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
☉ HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
☉ MetaboLights: a metabolomics database [PMID: 27010336].
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].
  NP Quantity Composition/Concentration
| Organism ID |
Organism Name |
Organism Material Preparation |
Organism Part |
NP Quantity (Standard) |
NP Quantity (Minimum) |
NP Quantity (Maximum) |
Quantity Unit |
Reference |
Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
☉ DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
☉ PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].
Biological Activity
| Activity Type |
# Activity |
| Potency |
3 |
| Inhibition |
9 |
| AC50 |
32 |
| HepSE_bilirubinemia |
1 |
| HepSE_cholecystitis |
1 |
| HepSE_cholelithiasis |
1 |
| HepSE_cirrhosis |
1 |
| HepSE_hepatic failure |
1 |
| HepSE_hepatic necrosis |
1 |
| HepSE_hepatomegaly |
1 |
| HepSE_jaundice |
2 |
| HepSE_liver fatty |
1 |
| HepSE_liver function tests abnormal |
1 |
| HepSE_Combined Scores |
1 |
| IC50 |
2 |
| HepSE_liver disease |
1 |
| HepSE_elevated liver function tests |
1 |
| HepSE_hepatitis |
1 |
| Activity Type |
# Activity |
| Individual protein |
34 |
| Organism |
7 |
| Single protein |
2 |
| Others |
3 |
| Phenotype |
15 |
Molecular-level activity
| Target ID |
Target Type |
Target Name |
Target Organism |
Activity Type |
Activity Relation |
Value |
Unit |
Reference |
| NPT242 |
Individual protein |
Dopamine D1 receptor |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT262 |
Individual protein |
Muscarinic acetylcholine receptor M1 |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT145 |
Individual protein |
Mu opioid receptor |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT261 |
Individual protein |
Monoamine oxidase A |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT228 |
Individual protein |
Norepinephrine transporter |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT222 |
Individual protein |
Alpha-2a adrenergic receptor |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT246 |
Individual protein |
Dopamine transporter |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT244 |
Individual protein |
Dopamine D3 receptor |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT2769 |
Individual protein |
Thromboxane A2 receptor |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT1788 |
Individual protein |
Alpha-1a adrenergic receptor |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT1410 |
Individual protein |
GABA receptor alpha-1 subunit |
Rattus norvegicus |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT108 |
Individual protein |
Estrogen receptor alpha |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT30 |
Individual protein |
Cyclooxygenase-1 |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT263 |
Individual protein |
Muscarinic acetylcholine receptor M2 |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT153 |
Individual protein |
Androgen Receptor |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT295 |
Individual protein |
Serotonin transporter |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT204 |
Individual protein |
Acetylcholinesterase |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT2761 |
Individual protein |
Phosphodiesterase 4A |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT291 |
Individual protein |
Serotonin 2b (5-HT2b) receptor |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT216 |
Individual protein |
Adenosine A1 receptor |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT483 |
Individual protein |
Prelamin-A/C |
Homo sapiens |
Potency |
= |
6.3 |
nM |
PubChem BioAssay data set |
| NPT987 |
Individual protein |
Histamine H3 receptor |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT20556 |
Single protein |
Replicase polyprotein 1ab |
Severe acute respiratory syndrome coronavirus 2 |
Inhibition |
= |
30.68 |
% |
DOI[10.6019/CHEMBL4495564] |
| NPT20556 |
Single protein |
Replicase polyprotein 1ab |
Severe acute respiratory syndrome coronavirus 2 |
Inhibition |
= |
4.951 |
% |
DOI[10.6019/CHEMBL4495564] |
| NPT692 |
Individual protein |
Histone deacetylase 6 |
Homo sapiens |
Inhibition |
= |
0.67 |
% |
HDAC6 screening dataset using tau-based substrate in an enzymatic assay yields selective inhibitors and activators |
| NPT692 |
Individual protein |
Histone deacetylase 6 |
Homo sapiens |
Inhibition |
= |
1.52 |
% |
HDAC6 screening dataset using tau-based substrate in an enzymatic assay yields selective inhibitors and activators |
| NPT542 |
Individual protein |
Progesterone receptor |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT98 |
Individual protein |
HERG |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT46 |
Individual protein |
Thyroid hormone receptor beta-1 |
Homo sapiens |
Potency |
n.a. |
158.5 |
nM |
PubChem BioAssay data set |
| NPT92 |
Individual protein |
Serotonin 1a (5-HT1a) receptor |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT5104 |
Individual protein |
Phosphodiesterase 3A |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT670 |
Individual protein |
Thrombin |
Homo sapiens |
AC50 |
= |
9020.1 |
nM |
PMID[37468498] |
In vitro activity
| Target ID |
Target Type |
Target Name |
Target Organism |
Activity Type |
Activity Relation |
Value |
Unit |
Reference |
| NPT20555 |
Organism |
SARS-CoV-2 |
Severe acute respiratory syndrome coronavirus 2 |
Inhibition |
= |
22.47 |
% |
DOI[10.21203/rs.3.rs-23951/v1] |
| NPT20555 |
Organism |
SARS-CoV-2 |
Severe acute respiratory syndrome coronavirus 2 |
Inhibition |
= |
0.04 |
% |
DOI[10.6019/CHEMBL4495565] |
| NPT20555 |
Organism |
SARS-CoV-2 |
Severe acute respiratory syndrome coronavirus 2 |
Inhibition |
= |
-0.18 |
% |
DOI[10.6019/CHEMBL4495565] |
| NPT20555 |
Organism |
SARS-CoV-2 |
Severe acute respiratory syndrome coronavirus 2 |
IC50 |
> |
20000.0 |
nM |
DOI[10.6019/CHEMBL4651402] |
| NPT20555 |
Organism |
SARS-CoV-2 |
Severe acute respiratory syndrome coronavirus 2 |
IC50 |
> |
19952.62 |
nM |
DOI[10.6019/CHEMBL4651402] |
| NPT2 |
Others |
Unspecified |
n.a. |
Potency |
n.a. |
4.7 |
nM |
PubChem BioAssay data set |
| NPT20596 |
Phenotype |
Hepatotoxicity |
n.a. |
HepSE_bilirubinemia |
= |
0.0 |
n.a. |
PMID[22194678] |
| NPT20596 |
Phenotype |
Hepatotoxicity |
n.a. |
HepSE_cholecystitis |
= |
0.0 |
n.a. |
PMID[22194678] |
| NPT20596 |
Phenotype |
Hepatotoxicity |
n.a. |
HepSE_cholelithiasis |
= |
0.0 |
n.a. |
PMID[22194678] |
| NPT20596 |
Phenotype |
Hepatotoxicity |
n.a. |
HepSE_cirrhosis |
= |
0.0 |
n.a. |
PMID[22194678] |
| NPT20596 |
Phenotype |
Hepatotoxicity |
n.a. |
HepSE_hepatic failure |
= |
0.0 |
n.a. |
PMID[22194678] |
| NPT20596 |
Phenotype |
Hepatotoxicity |
n.a. |
HepSE_hepatic necrosis |
= |
0.0 |
n.a. |
PMID[22194678] |
| NPT20596 |
Phenotype |
Hepatotoxicity |
n.a. |
HepSE_hepatomegaly |
= |
0.0 |
n.a. |
PMID[22194678] |
| NPT20596 |
Phenotype |
Hepatotoxicity |
n.a. |
HepSE_jaundice |
= |
0.0 |
n.a. |
PMID[22194678] |
| NPT20596 |
Phenotype |
Hepatotoxicity |
n.a. |
HepSE_liver fatty |
= |
0.0 |
n.a. |
PMID[22194678] |
| NPT20596 |
Phenotype |
Hepatotoxicity |
n.a. |
HepSE_liver function tests abnormal |
= |
0.0 |
n.a. |
PMID[22194678] |
| NPT20596 |
Phenotype |
Hepatotoxicity |
n.a. |
HepSE_Combined Scores |
= |
0.0 |
n.a. |
PMID[22194678] |
| NPT2 |
Others |
Unspecified |
n.a. |
AC50 |
n.a. |
5011.9 |
nM |
PubChem BioAssay data set |
| NPT2 |
Others |
Unspecified |
n.a. |
AC50 |
n.a. |
1258.9 |
nM |
PubChem BioAssay data set |
| NPT20596 |
Phenotype |
Hepatotoxicity |
n.a. |
HepSE_liver disease |
= |
0.0 |
n.a. |
PMID[22194678] |
In vivo activity
| Target ID |
Target Type |
Target Name |
Target Organism |
Activity Type |
Activity Relation |
Value |
Unit |
Reference |
| NPT20596 |
Phenotype |
Hepatotoxicity |
n.a. |
HepSE_elevated liver function tests |
= |
0.0 |
n.a. |
PMID[22194678] |
| NPT20596 |
Phenotype |
Hepatotoxicity |
n.a. |
HepSE_hepatitis |
= |
0.0 |
n.a. |
PMID[22194678] |
Experimental ADME
| Experiment Model |
Experiment Tissue |
ADME Type |
ADME Relation |
ADME Value |
ADME Unit |
Reference |
  Chemically structural similarity
Similar Active Natural Products in NPASS
Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)
Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.
●  The left chart: Distribution of similarity level between NPC261181 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).
| range |
Tanimoto Coefficient |
| 0-0.1 | 32538 |
| 0.1-0.2 | 15741 |
| 0.2-0.3 | 1444 |
| 0.3-0.4 | 125 |
| 0.4-0.5 | 9 |
| 0.5-0.6 | 1 |
| 0.6-0.7 | 0 |
| 0.7-0.8 | 0 |
| 0.8-0.85 | 0 |
| 0.85-0.9 | 0 |
| 0.9-0.95 | 0 |
| 0.95-1 | 0 |
| Similarity Score |
Similarity Level |
Natural Product ID |
| 0.52 |
Remote Similarity |
NPC130398 |
Similar Clinical/Approved Drugs
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC261181 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).
| range |
Tanimoto Coefficient |
| 0-0.1 | 4374 |
| 0.1-0.2 | 4337 |
| 0.2-0.3 | 428 |
| 0.3-0.4 | 7 |
| 0.4-0.5 | 3 |
| 0.5-0.6 | 0 |
| 0.6-0.7 | 0 |
| 0.7-0.8 | 0 |
| 0.8-0.85 | 0 |
| 0.85-0.9 | 0 |
| 0.9-0.95 | 0 |
| 0.95-1 | 1 |
| Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
| 1.0 |
High Similarity |
NPD1202 |
Phase 4 |